lovastatin has been researched along with Peroxisomal Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contreras, MA; Haq, E; Khan, M; Paintlia, AS; Paintlia, MK; Singh, AK; Singh, I; Stanislaus, R | 1 |
| Grillhofer, H; Kostner, GM; Malle, E; Oettl, K; Sattler, W | 1 |
2 other study(ies) available for lovastatin and Peroxisomal Disorders
| Article | Year |
|---|---|
Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment.
Topics: Acyl-CoA Oxidase; Acyltransferases; Adenosine Triphosphatases; Animals; Anticholesteremic Agents; ATP-Binding Cassette Transporters; ATPases Associated with Diverse Cellular Activities; Catalase; Central Nervous System; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Fatty Acids; Female; Freund's Adjuvant; Immunohistochemistry; Inflammation; Lovastatin; Membrane Proteins; Microarray Analysis; Peroxisomal Disorders; Peroxisomes; Rats; Rats, Inbred Lew; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2004 |
Cholesterol metabolism in cells with different peroxisomal defects.
Topics: Animals; Anticholesteremic Agents; CHO Cells; Cholesterol; Cricetinae; Down-Regulation; Enzyme Inhibitors; Fatty Acids; Fibroblasts; Homeostasis; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins; Lovastatin; Oleic Acid; Peroxisomal Disorders | 1996 |